![Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease | Nature Reviews Neuroscience Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease | Nature Reviews Neuroscience](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrn2915/MediaObjects/41583_2010_Article_BFnrn2915_Fig1_HTML.jpg)
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease | Nature Reviews Neuroscience
![Parkinson disease and the immune system — associations, mechanisms and therapeutics | Nature Reviews Neurology Parkinson disease and the immune system — associations, mechanisms and therapeutics | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-020-0344-4/MediaObjects/41582_2020_344_Fig1_HTML.png)
Parkinson disease and the immune system — associations, mechanisms and therapeutics | Nature Reviews Neurology
![Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? | Nature Reviews Neuroscience Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? | Nature Reviews Neuroscience](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41583-021-00542-9/MediaObjects/41583_2021_542_Fig1_HTML.png)
Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? | Nature Reviews Neuroscience
![Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies | Nature Reviews Neuroscience Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies | Nature Reviews Neuroscience](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrn3549/MediaObjects/41583_2013_Article_BFnrn3549_Fig1_HTML.jpg)
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies | Nature Reviews Neuroscience
![iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates | Nature Medicine iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-019-0739-1/MediaObjects/41591_2019_739_Fig1_HTML.png)
iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates | Nature Medicine
![Biology | Free Full-Text | Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms Biology | Free Full-Text | Clinical Features of Parkinson's Disease: The Evolution of Critical Symptoms](https://pub.mdpi-res.com/biology/biology-09-00103/article_deploy/html/images/biology-09-00103-g001.png?1589890467)